{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:39:15Z","timestamp":1788305955629,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s40618-019-01046-1","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T03:02:47Z","timestamp":1554778967000},"page":"1241-1244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Adherence to growth hormone (GH) therapy in na\u00efve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS)"],"prefix":"10.1007","volume":"42","author":[{"name":"the Italian ECOS Investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Centonze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Guzzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Loche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,9]]},"reference":[{"key":"1046_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000452150","volume":"86","author":"A Grimberg","year":"2016","unstructured":"Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, Rossi WC, Feudtner C, Murad MH (2016) Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr 86:361\u2013397","journal-title":"Horm Res Paediatr"},{"key":"1046_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2265.2012.04420.x","volume":"77","author":"P Bang","year":"2012","unstructured":"Bang P, Ahmed SF, Argente J, Backeljauw P, Bettendorf M, Bona G et al (2012) Identification and management of poor response to growth-promoting therapy in children with short stature. Clin Endocrinol (Oxf) 77:169\u2013181","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1046_CR3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1365-2265.2009.03775.x","volume":"72","author":"MO Savage","year":"2010","unstructured":"Savage MO, Burren CP, Rosenfeld RG (2010) The continuum of growth hormone-IGF-I axis defects causing short stature: diagnostic and therapeutic challenges. Clin Endocrinol 72:721\u2013728","journal-title":"Clin Endocrinol"},{"key":"1046_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s40618-017-0816-6","volume":"41","author":"G Migliaretti","year":"2018","unstructured":"Migliaretti G, Ditaranto S, Gulot C, Vannelli S, Matarazzo P, Cappello N et al (2018) Long-term response to recombinant human growth hormone treatment: a new predictive mathematical method. J Endocrinol Investig 41:839\u2013848","journal-title":"J Endocrinol Investig"},{"key":"1046_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg Osterberg","year":"2005","unstructured":"Osterberg Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487\u2013497","journal-title":"N Engl J Med"},{"key":"1046_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1651-2227.1998.tb01464.x","volume":"87","author":"M Oyarzabal","year":"1998","unstructured":"Oyarzabal M, Aliaga M, Chueca M, Echarte G, Ulied A (1998) Multicentre survey on compliance with growth hormone therapy: what can be improved? Acta Paediatr 87:387\u2013391","journal-title":"Acta Paediatr"},{"key":"1046_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/adc.68.1.91","volume":"68","author":"S Smith","year":"1993","unstructured":"Smith S, Hindmarsh P, Brook C (1993) Compliance with growth hormone treatment\u2014are they getting it? Arch Dis Child 68:91\u201393","journal-title":"Arch Dis Child"},{"key":"1046_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.4158\/EP171786.OR","volume":"23","author":"F Bagnasco","year":"2017","unstructured":"Bagnasco F, Di Iorgi N, Roveda A, Gallizia A, Haupt R, Maghnie M (2017) Prevalence and correlates of adherence in children and adolescents treated with growth hormone. A multicenter Italian study. Endocr Pract 23:929\u2013941","journal-title":"Endocr Pract"},{"key":"1046_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4158\/EP.14.2.143","volume":"14","author":"R Rosenfeld","year":"2008","unstructured":"Rosenfeld R, Bakker B (2008) Compliance and persistence in pediatric and adult patients receiving growth hormone therapy. Endocr Pract 14:143\u2013154","journal-title":"Endocr Pract"},{"key":"1046_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4158\/EP13194.OR","volume":"20","author":"B Aydin","year":"2014","unstructured":"Aydin B, Aycan Z, Siklar Z et al (2014) Adherence to growth hormone therapy: results of a multicenter study. Endocr Pract 20:46\u201351","journal-title":"Endocr Pract"},{"key":"1046_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/adc.2006.114249","volume":"93","author":"R Kapoor","year":"2008","unstructured":"Kapoor R, Burke S, Sparrow S, Hughes I, Dunger D, Ong K, Acerini C (2008) Monitoring of concordance in growth hormone therapy. Arch Dis Child 93:147\u2013148","journal-title":"Arch Dis Child"},{"key":"1046_CR12","doi-asserted-by":"publisher","first-page":"e16223","DOI":"10.1371\/journal.pone.0016223","volume":"6","author":"WS Cutfield","year":"2011","unstructured":"Cutfield WS, Derraik JG, Gunn AJ, Reid K, Delany T, Robinson E, Hofman PL (2011) Non-compliance with growth hormone treatment in children is common and impairs linear growth. PLoS One 6:e16223","journal-title":"PLoS One"},{"key":"1046_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000350251","volume":"79","author":"BG Fisher","year":"2013","unstructured":"Fisher BG, Acerini CL (2013) Understanding the growth hormone therapy adherence paradigm: a systematic review. Horm Res Paediatr 79:189\u2013196","journal-title":"Horm Res Paediatr"},{"key":"1046_CR14","first-page":"327","volume":"2","author":"P Desrosiers","year":"2005","unstructured":"Desrosiers P, O\u2019Brien F, Blethen S (2005) Patient outcomes in the GH monitor: the effect of delivery device on compliance and growth. Pediatr Endocrinol Rev 2:327\u2013331","journal-title":"Pediatr Endocrinol Rev"},{"key":"1046_CR15","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1185\/030079907X210589","volume":"23","author":"J Dahlgren","year":"2007","unstructured":"Dahlgren J, Veimo D, Johansson L, Bech I (2007) Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use. Curr Med Res Opin 23:1649\u20131655","journal-title":"Curr Med Res Opin"},{"key":"1046_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6823-11-4","volume":"11","author":"M Bozzola","year":"2011","unstructured":"Bozzola M, Colle M, Halldin-Stenlid M, Larroque S, Zignani M (2011) Treatment adherence with the easypod growth hormone electronic auto-injector and patient acceptance: survey results from 824 children and their parents. BMC Endocr Disord 11:4\u201313","journal-title":"BMC Endocr Disord"},{"key":"1046_CR17","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s40618-016-0510-0","volume":"39","author":"S Loche","year":"2016","unstructured":"Loche S, Salerno M, Garofalo P, Cardinale GM, Licenziati MR, Citro G et al (2016) Adherence in children with growth hormone deficiency treated with r-hGH and the easypod device. J Endocrinol Investig 39:1419\u20131424","journal-title":"J Endocrinol Investig"},{"key":"1046_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000351800","volume":"80","author":"K Hartmann","year":"2013","unstructured":"Hartmann K, Ittner J, Muller-Rossberg E, Schonau E, Stephan R, Ullrich KP, Hoppe B, Ramseger R, Bramswig J (2013) Growth hormone treatment adherence in prepubertal and pubertal children with different growth disorders. Horm Res Paediatr 80:1\u20135","journal-title":"Horm Res Paediatr"},{"key":"1046_CR19","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1530\/EC-18-0172","volume":"7","author":"E Koledova","year":"2018","unstructured":"Koledova E, Stoyanov G, Ovbude L, Davies PSW (2018) Adherence and long-term growth outcomes: results from the easypod connect observational study (ECOS) in paediatric patients with growth disorders. Endocr Connect 7:914\u2013923","journal-title":"Endocr Connect"},{"key":"1046_CR20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000437305","volume":"84","author":"N Lass","year":"2015","unstructured":"Lass N, Reinehr T (2015) Low treatment adherence in pubertal children treated with thyroxine or growth hormone. Horm Res Paediatr 84:240\u2013247","journal-title":"Horm Res Paediatr"},{"key":"1046_CR21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1210\/jc.2007-1581","volume":"93","author":"B Bakker","year":"2008","unstructured":"Bakker B, Frane J, Anhalt R, Lippe B, Rosenfeld RG (2008) Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children. J Clin Endocrinol Metab 93:352\u2013357","journal-title":"J Clin Endocrinol Metab"},{"key":"1046_CR22","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1210\/jc.2009-1471","volume":"95","author":"MB Ranke","year":"2010","unstructured":"Ranke MB, Lindberg A, On Behalf of the Kigs International Board (2010) Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables. J Clin Endocrinol Metab 95:1229\u20131237","journal-title":"J Clin Endocrinol Metab"},{"key":"1046_CR23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.beem.2016.11.008","volume":"30","author":"N Iorgi Di","year":"2016","unstructured":"Di Iorgi N, Morana G, Allegri AME, Napoli F, Gastaldi R, Calcagno A, Patti G, Loche S, Maghnie M (2016) Clasical and non-classical causes of GH deficiency in the paediatric age. Best Pract Res Clin Endocrinol Metab 30:705\u2013736","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1046_CR24","unstructured":"www.agenziafarmaco.gov\/content\/note-aifa"},{"key":"1046_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206009","author":"P Dommelen Van","year":"2018","unstructured":"Van Dommelen P, Koledova E, Wit JM (2018) Effect of adherence to growth hormone treatment on 0\u20132\u00a0year catch-up growth in children with growth hormone deficiency. PLoS One. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0206009","journal-title":"PLoS One"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01046-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-019-01046-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01046-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T19:19:49Z","timestamp":1586287189000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-019-01046-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,9]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["1046"],"URL":"https:\/\/doi.org\/10.1007\/s40618-019-01046-1","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,9]]},"assertion":[{"value":"29 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Chiara Centonze and Giovanna Orlando are Employees of Merck Serono. Sandro Loche is member of the ECOS International Steering Committee and has received research support and lecture fees from Merck Serono.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local ethical committees.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patients and\/or from their legal guardians prior to their enrollment in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}